IBDEI34U ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,50029,2)
;;=^5009055
;;^UTILITY(U,$J,358.3,50030,0)
;;=L03.322^^193^2487^15
;;^UTILITY(U,$J,358.3,50030,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50030,1,3,0)
;;=3^Acute Lymphangitis of Back
;;^UTILITY(U,$J,358.3,50030,1,4,0)
;;=4^L03.322
;;^UTILITY(U,$J,358.3,50030,2)
;;=^5009056
;;^UTILITY(U,$J,358.3,50031,0)
;;=L03.323^^193^2487^16
;;^UTILITY(U,$J,358.3,50031,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50031,1,3,0)
;;=3^Acute Lymphangitis of Chest Wall
;;^UTILITY(U,$J,358.3,50031,1,4,0)
;;=4^L03.323
;;^UTILITY(U,$J,358.3,50031,2)
;;=^5009057
;;^UTILITY(U,$J,358.3,50032,0)
;;=L03.324^^193^2487^18
;;^UTILITY(U,$J,358.3,50032,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50032,1,3,0)
;;=3^Acute Lymphangitis of Groin
;;^UTILITY(U,$J,358.3,50032,1,4,0)
;;=4^L03.324
;;^UTILITY(U,$J,358.3,50032,2)
;;=^5009058
;;^UTILITY(U,$J,358.3,50033,0)
;;=L03.325^^193^2487^24
;;^UTILITY(U,$J,358.3,50033,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50033,1,3,0)
;;=3^Acute Lymphangitis of Perineum
;;^UTILITY(U,$J,358.3,50033,1,4,0)
;;=4^L03.325
;;^UTILITY(U,$J,358.3,50033,2)
;;=^5009059
;;^UTILITY(U,$J,358.3,50034,0)
;;=L03.326^^193^2487^30
;;^UTILITY(U,$J,358.3,50034,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50034,1,3,0)
;;=3^Acute Lymphangitis of Umbilicus
;;^UTILITY(U,$J,358.3,50034,1,4,0)
;;=4^L03.326
;;^UTILITY(U,$J,358.3,50034,2)
;;=^5009060
;;^UTILITY(U,$J,358.3,50035,0)
;;=L03.329^^193^2487^29
;;^UTILITY(U,$J,358.3,50035,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50035,1,3,0)
;;=3^Acute Lymphangitis of Trunk,Unspec
;;^UTILITY(U,$J,358.3,50035,1,4,0)
;;=4^L03.329
;;^UTILITY(U,$J,358.3,50035,2)
;;=^5009062
;;^UTILITY(U,$J,358.3,50036,0)
;;=L08.9^^193^2487^171
;;^UTILITY(U,$J,358.3,50036,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50036,1,3,0)
;;=3^Local Infection of Skin/Subcutaneous Tissue,Unspec
;;^UTILITY(U,$J,358.3,50036,1,4,0)
;;=4^L08.9
;;^UTILITY(U,$J,358.3,50036,2)
;;=^5009082
;;^UTILITY(U,$J,358.3,50037,0)
;;=L11.0^^193^2487^10
;;^UTILITY(U,$J,358.3,50037,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50037,1,3,0)
;;=3^Acquired Keratosis Follicularis
;;^UTILITY(U,$J,358.3,50037,1,4,0)
;;=4^L11.0
;;^UTILITY(U,$J,358.3,50037,2)
;;=^5009091
;;^UTILITY(U,$J,358.3,50038,0)
;;=L20.0^^193^2487^91
;;^UTILITY(U,$J,358.3,50038,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50038,1,3,0)
;;=3^Besnier's Prurigo
;;^UTILITY(U,$J,358.3,50038,1,4,0)
;;=4^L20.0
;;^UTILITY(U,$J,358.3,50038,2)
;;=^5009107
;;^UTILITY(U,$J,358.3,50039,0)
;;=L20.81^^193^2487^88
;;^UTILITY(U,$J,358.3,50039,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50039,1,3,0)
;;=3^Atopic Neurodermatitis
;;^UTILITY(U,$J,358.3,50039,1,4,0)
;;=4^L20.81
;;^UTILITY(U,$J,358.3,50039,2)
;;=^5009108
;;^UTILITY(U,$J,358.3,50040,0)
;;=L20.82^^193^2487^153
;;^UTILITY(U,$J,358.3,50040,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50040,1,3,0)
;;=3^Flexural Eczema
;;^UTILITY(U,$J,358.3,50040,1,4,0)
;;=4^L20.82
;;^UTILITY(U,$J,358.3,50040,2)
;;=^5009109
;;^UTILITY(U,$J,358.3,50041,0)
;;=L20.84^^193^2487^165
;;^UTILITY(U,$J,358.3,50041,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50041,1,3,0)
;;=3^Intrinsic Eczema
;;^UTILITY(U,$J,358.3,50041,1,4,0)
;;=4^L20.84
;;^UTILITY(U,$J,358.3,50041,2)
;;=^5009111
;;^UTILITY(U,$J,358.3,50042,0)
;;=L20.89^^193^2487^86
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI34U 3761 printed Sep 15, 2024@22:06:02 Page 2
IBDEI34U ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,50029,2)
+2 ;;=^5009055
+3 ;;^UTILITY(U,$J,358.3,50030,0)
+4 ;;=L03.322^^193^2487^15
+5 ;;^UTILITY(U,$J,358.3,50030,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,50030,1,3,0)
+8 ;;=3^Acute Lymphangitis of Back
+9 ;;^UTILITY(U,$J,358.3,50030,1,4,0)
+10 ;;=4^L03.322
+11 ;;^UTILITY(U,$J,358.3,50030,2)
+12 ;;=^5009056
+13 ;;^UTILITY(U,$J,358.3,50031,0)
+14 ;;=L03.323^^193^2487^16
+15 ;;^UTILITY(U,$J,358.3,50031,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,50031,1,3,0)
+18 ;;=3^Acute Lymphangitis of Chest Wall
+19 ;;^UTILITY(U,$J,358.3,50031,1,4,0)
+20 ;;=4^L03.323
+21 ;;^UTILITY(U,$J,358.3,50031,2)
+22 ;;=^5009057
+23 ;;^UTILITY(U,$J,358.3,50032,0)
+24 ;;=L03.324^^193^2487^18
+25 ;;^UTILITY(U,$J,358.3,50032,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,50032,1,3,0)
+28 ;;=3^Acute Lymphangitis of Groin
+29 ;;^UTILITY(U,$J,358.3,50032,1,4,0)
+30 ;;=4^L03.324
+31 ;;^UTILITY(U,$J,358.3,50032,2)
+32 ;;=^5009058
+33 ;;^UTILITY(U,$J,358.3,50033,0)
+34 ;;=L03.325^^193^2487^24
+35 ;;^UTILITY(U,$J,358.3,50033,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,50033,1,3,0)
+38 ;;=3^Acute Lymphangitis of Perineum
+39 ;;^UTILITY(U,$J,358.3,50033,1,4,0)
+40 ;;=4^L03.325
+41 ;;^UTILITY(U,$J,358.3,50033,2)
+42 ;;=^5009059
+43 ;;^UTILITY(U,$J,358.3,50034,0)
+44 ;;=L03.326^^193^2487^30
+45 ;;^UTILITY(U,$J,358.3,50034,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,50034,1,3,0)
+48 ;;=3^Acute Lymphangitis of Umbilicus
+49 ;;^UTILITY(U,$J,358.3,50034,1,4,0)
+50 ;;=4^L03.326
+51 ;;^UTILITY(U,$J,358.3,50034,2)
+52 ;;=^5009060
+53 ;;^UTILITY(U,$J,358.3,50035,0)
+54 ;;=L03.329^^193^2487^29
+55 ;;^UTILITY(U,$J,358.3,50035,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,50035,1,3,0)
+58 ;;=3^Acute Lymphangitis of Trunk,Unspec
+59 ;;^UTILITY(U,$J,358.3,50035,1,4,0)
+60 ;;=4^L03.329
+61 ;;^UTILITY(U,$J,358.3,50035,2)
+62 ;;=^5009062
+63 ;;^UTILITY(U,$J,358.3,50036,0)
+64 ;;=L08.9^^193^2487^171
+65 ;;^UTILITY(U,$J,358.3,50036,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,50036,1,3,0)
+68 ;;=3^Local Infection of Skin/Subcutaneous Tissue,Unspec
+69 ;;^UTILITY(U,$J,358.3,50036,1,4,0)
+70 ;;=4^L08.9
+71 ;;^UTILITY(U,$J,358.3,50036,2)
+72 ;;=^5009082
+73 ;;^UTILITY(U,$J,358.3,50037,0)
+74 ;;=L11.0^^193^2487^10
+75 ;;^UTILITY(U,$J,358.3,50037,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,50037,1,3,0)
+78 ;;=3^Acquired Keratosis Follicularis
+79 ;;^UTILITY(U,$J,358.3,50037,1,4,0)
+80 ;;=4^L11.0
+81 ;;^UTILITY(U,$J,358.3,50037,2)
+82 ;;=^5009091
+83 ;;^UTILITY(U,$J,358.3,50038,0)
+84 ;;=L20.0^^193^2487^91
+85 ;;^UTILITY(U,$J,358.3,50038,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,50038,1,3,0)
+88 ;;=3^Besnier's Prurigo
+89 ;;^UTILITY(U,$J,358.3,50038,1,4,0)
+90 ;;=4^L20.0
+91 ;;^UTILITY(U,$J,358.3,50038,2)
+92 ;;=^5009107
+93 ;;^UTILITY(U,$J,358.3,50039,0)
+94 ;;=L20.81^^193^2487^88
+95 ;;^UTILITY(U,$J,358.3,50039,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,50039,1,3,0)
+98 ;;=3^Atopic Neurodermatitis
+99 ;;^UTILITY(U,$J,358.3,50039,1,4,0)
+100 ;;=4^L20.81
+101 ;;^UTILITY(U,$J,358.3,50039,2)
+102 ;;=^5009108
+103 ;;^UTILITY(U,$J,358.3,50040,0)
+104 ;;=L20.82^^193^2487^153
+105 ;;^UTILITY(U,$J,358.3,50040,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,50040,1,3,0)
+108 ;;=3^Flexural Eczema
+109 ;;^UTILITY(U,$J,358.3,50040,1,4,0)
+110 ;;=4^L20.82
+111 ;;^UTILITY(U,$J,358.3,50040,2)
+112 ;;=^5009109
+113 ;;^UTILITY(U,$J,358.3,50041,0)
+114 ;;=L20.84^^193^2487^165
+115 ;;^UTILITY(U,$J,358.3,50041,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,50041,1,3,0)
+118 ;;=3^Intrinsic Eczema
+119 ;;^UTILITY(U,$J,358.3,50041,1,4,0)
+120 ;;=4^L20.84
+121 ;;^UTILITY(U,$J,358.3,50041,2)
+122 ;;=^5009111
+123 ;;^UTILITY(U,$J,358.3,50042,0)
+124 ;;=L20.89^^193^2487^86
